Arvinas, Inc. (ARVN) vs DiaMedica Therapeutics, Inc. (DMAC)

• Arvinas, Inc. ARVN 7.56 ▼ −3.82%
• DiaMedica Therapeutics, Inc. DMAC 9.32 ▲ +0.76%

Arvinas, Inc. and DiaMedica Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and DiaMedica Therapeutics, Inc. are of similar size ($513.9M and $498.8M). DiaMedica Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 41.0×. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Arvinas, Inc. leads on 8 and DiaMedica Therapeutics, Inc. on 5.